That's the old saying, anyway. Though there are many who feel that pharma sales reps' detailing of docs can lead to some deviltry--or at least, bad doctoring. I just heard today about a new nonprofit that's forming something called the Counter-detailing Initiative. From the CDI Web site:
CDI plans on being the "checks and balance" infrastructure that will fill the void between industry bias and true objectivity.
For more on this initiative, e-mail CDI. What do you think? Is there a need for this initiative? While it might be pie-in-the-sky dreaming at this point, I'd love to see CME get out of the ballroom and into individual practices through academic detailing, perhaps with Web backup. But at least this would be a start. I just wonder how on earth they can fund it.
To comment on this post, click on "comments" below. To receive a weekly update, e-mail Sue.